2021 Survivor’s Reunion

Unfortunately the Survivor’s Reunion will not take place this year. Dr Iddings is planning on resuming it next year however, December 2022. We wish you all a wonderful and safe holiday season!

Dr Iddings Has Moved

Dr Iddings 5-year Patient Choice Award!

2011 Most Compassionate Doctor Award

The 2011 patient reviews have been totaled, and you were selected by your patients for the Compassionate Doctor Recognition!

Congratulations Dr. Iddings,

Treating patients, not just the disease, is what you excel at, and your patients appreciate the kindness you have dispensed along with your medical care.

This award is based on reviews written by hundreds of thousands of patients. While physicians generally receive positive feedback from their patients, only a select few receive praise about the compassion that accompanied their care. In fact, of the nation’s 720,000 active physicians, less than 3% were accorded this honor by their patients in 2011.

Congratulations on perhaps the most important recognition a doctor can receive, the recognition of their patients.

Taylor Green
1-866-964-0866 x2
tgreen@americanregistry.com

All About Robotic Surgery – Spotlight Feature – Dr. Iddings

Welcome to our Fourth Issue of

Our “Spotlight Feature” Series

in which we will highlight;

Dr. Douglas M. Iddings FACS
Fellowship Trained Surgical Oncologist

Special Expertise:
Endocrine Surgery; Thyroid, Parathyroid, Adrenal.
Gynecologic Oncology; Head and Neck Squamous cell carcinoma.
Hepatobiliary Surgery; Liver, Pancreas, Melanoma.
Robotic Oncologic Surgery; Soft Tissue Cancer Sarcoma.
Surgical Oncology

CLICK HERE TO READ THE SPOTLIGHT FEATURE –

DR. IDDINGS AT ALLABOUTROBOTICSURGERY.COM

2011 Patient’s Choice Award

Patient’s Choice Award

Nov 1, 2011

Douglas M Iddings, DO
8384 Holly Rd
Grand Blanc, MI, 48439-1974

Dear Dr. Iddings:

Congratulations! You have once again been recognized as a Patients’ Choice physician.

Every month, more than 200,000 patients across the U.S. provide online feedback about their doctor experiences. They rate various components of the care they receive, such as bedside manner, doctor-patient face time, follow-up care, ease of appointment setting, courtesy of office staff, and they also share their overall opinions.

Over the course of 2011, hundreds of thousands of patient reviews were written and shared. While physicians generally receive positive feedback from their patients, only a select few consistently receive rave reviews. Of those with high praise, only physicians like yourself – with near perfect scores – have been voted by their patients for this honor.

In fact, of the nation’s 720,000 active physicians, less than 6 percent were accorded this honor by their patients in 2010.

You are, indeed, the Patients’ Choice; a physician so highly regarded by their patients that they feel the need to talk to others about the positive influence of your work.

This notation of your distinction as a 2011 Patients’ Choice physician will be prominently displayed in your Profile on a broad collection of web sites, including PatientsChoice, Vitals, Google, and a variety of Managed Care sites. More than 500,000 people view these websites on a daily basis.

To ensure all aspects of your profile are correct, please go to www.vitals.com and click “login: physician” in the upper right hand corner of the site; there you will be able to log in using your previously registered email and password, or if you have not previously registered you will be able to do so by clicking “get started.”

Congratulations once again on this outstanding distinction.

Sincerely,

Erika Boyer
Vice President, Consumer Research

 

 

 

 

 

 

 

 

 

The “Patients’ Choice” award is tabulated by MDx Medical, Inc.

MDx Medical, Inc. 1200 Wall Street West, Lyndhurst, NJ 07071 T. 201.624.2480 F. 201.438.4555

CNN Airport Radio Interview with Dr. Douglas Iddings

CNN Interview

CNN Airport Radio Interview with Dr. Douglas Iddings

Click on the CNN logo to listen to the interview.

2010 Most Compationate Doctor

	The 2010 patient reviews have been totaled, and you were selected by your patients for the Compassionate Doctor Recognition!

Congratulations Dr. Iddings,

Treating patients, not just the disease, is what you excel at, and your patients appreciate the kindness you have dispensed along with your medical care.

This award is based on reviews written by hundreds of thousands of patients. While physicians generally receive positive feedback from their patients, only a select few receive praise about the compassion that accompanied their care. In fact, of the nation’s 720,000 active physicians, less than 3% were accorded this honor by their patients in 2010.

Congratulations on perhaps the most important recognition a doctor can receive, the recognition of their patients.

Taylor Green
1-866-964-0866 x2
tgreen@americanregistry.com

ASCO.org News Releases

ASCO.org Recent News

www.Cancer.gov News Releases

http://www.cancer.gov/newscenter

Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups - From 1999—2019, US rates of cancer death fell among Black people. Yet, in 2019, their rates remained higher than those of other racial and ethnic groups. Uterine cancer deaths are rising in the United States, and are highest among Black women - Deaths from uterine cancer are rising in the United States, and are highest among non-Hispanic Black women, according to a new study led by researchers at NCI, part of the National Institutes of Health. The higher death rates are related to the rising incidence of aggressive subtypes of uterine cancer. Norman Sharpless steps down as director of the National Cancer Institute - Norman E. “Ned” Sharpless, M.D., announces his decision to step down as NCI director, a position he has held since 2017. NCI Principal Deputy Director Douglas R. Lowy, M.D., will serve as NCI’s acting director beginning April 30, 2022. NCI launches program to offer molecular characterization of childhood cancers - The Molecular Characterization Initiative will offer state-of-the-art diagnoses to children, adolescents, and young adults with central nervous system tumors. Gene expression profile could enable rapid identification of anti-tumor immune cells for personalized immunotherapy - NCI researchers have found unique expression profiles in 50 genes that help identify rare anti-tumor lymphocytes that can infiltrate and help defeat metastatic solid epithelial tumors. NCI study advances personalized immunotherapy for metastatic breast cancer - NCI researchers have shown that an experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer who have exhausted all other treatment options. A high-fiber diet may improve the response of melanoma patients to immunotherapy - NCI researchers have found that a diet rich in fiber may help some people being treated for melanoma respond to immunotherapy treatment by influencing the gut microbiome. The new findings come from an analysis of people with melanoma and mouse models of the disease. Drug combination helps children with acute promyelocytic leukemia avoid conventional chemotherapy - A Children’s Oncology Group trial shows that the combination of all-trans retinoic acid and arsenic trioxide is highly effective in children with acute promyelocytic leukemia. The therapy avoids or minimizes the use of conventional chemotherapy. Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma - NCI researchers have found that adding the targeted therapy ibrutinib (Imbruvica) to standard chemotherapy can improve how long some younger people with a specific form of diffuse large B-cell lymphoma live. The new findings come from a new analysis of a previously conducted phase 3 clinical trial called Phoenix. Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019 - Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.

Next Page »